)
Ugur Eskiocak, PhD
CEO and Co-Founder
Voro Therapeutics, Inc.
Ugur Eskiocak, PhD is the Co-Founder and CEO of Voro Therapeutics. Voro is developing oncology therapeutics through its category-defining, tumor-activated biologics platform. He has 20 years of experience in oncology research and drug development. He has advanced 6 immuno-oncology programs through IND-enabling studies and into the clinical trials in various leadership roles at Compass Therapeutics, Xilio Therapeutics, Takeda and Janux Therapeutics.
Sessions
-
23-Jun-20265BVoro Therapeutics, Inc.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}